Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01236768 · ClinicalTrials.gov registry record · Phase 3
Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm
A Phase 3 study, sponsored by Agile Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 407
- Enrollment target
NCT01236768: Completed Phase 3 study, sponsored by Agile Therapeutics.
NCT01236768 is a Phase 3 study that has completed, run by Agile Therapeutics. The registered enrollment target is 407 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01236768, a Phase 3 study, has completed, sponsored by Agile Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 407 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the efficacy and safety of a low dose transdermal contraceptive delivery system containing ethinyl estradiol and levonorgestrel.
Primary Outcome
Pearl Index is the number of on-therapy pregnancies times 1300 divided by the number of 28-day on-therapy cycles and is an estimate of the number of pregnancies per 100 woman-years of product use.
Interventions
- DRUG AG200-15
- DRUG Levora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 407 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-06 |
| Phase | Phase 3 |
What the finished NCT01236768 record still lists
NCT01236768 is an interventional study that assigns participants to a tested intervention. The registered 407 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which AG200-15 is the first listed.
NCT01236768 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01236768 about?
NCT01236768 is a clinical study titled "Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm". The purpose of the study is to evaluate the efficacy and safety of a low dose transdermal contraceptive delivery system containing ethinyl estradiol and levonorgestrel.
What is the current status of trial NCT01236768?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 407 participants. The study started on 2010-10. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01236768?
The interventions under investigation include: AG200-15 (DRUG), Levora (DRUG).
Who is sponsoring clinical trial NCT01236768?
This trial is sponsored by Agile Therapeutics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01236768's enrollment target sits among peer trials
407 913th of 2000 higher than 1,088 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06735534 · 407 participants · NA
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
- NCT07094516 · 407 participants · Phase 2
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- NCT04835428 · 408 participants · NA
STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures
- NCT05836324 · 408 participants · Phase 1
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia